Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-02-28 @ 2:28 PM
Study NCT ID:
NCT00615758
Status:
COMPLETED
Last Update Posted:
2009-12-15
First Post:
2008-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV
Sponsor:
Organization: